» Articles » PMID: 19855055

Mechanisms of Aortic Valve Calcification: the LDL-density-radius Theory: a Translation from Cell Signaling to Physiology

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Recent epidemiologic studies have revealed the risk factors associated for vascular atherosclerosis, including the male sex, smoking, hypertension, and elevated serum cholesterol, similar to the risk factors associated with the development of AV stenosis. An increasing number of models of experimental hypercholesterolemia demonstrate features of atherosclerosis in the AV, which are similar to the early stages of vascular atherosclerotic lesions. Experimental and clinical studies demonstrate that the hypercholesterolemic AV develops an atherosclerotic lesion which is proliferative and expresses high levels of osteoblast bone markers which mineralize over time to form bone. Calcification, the end-stage process of the disease, is necessary to understand as a prognostic indicator in the modification of this cellular process before it is too late. In summary, these findings suggest that medical therapies may have a potential role in patients in the early stages of this disease process to slow the progression to severe aortic stenosis and to delay the timing of the need for surgery. The translation of these experimental studies to clinical practice will be important to understand the potential for medical therapy for this disease process.

Citing Articles

Short-term therapy with R568 ameliorated secondary hyperparathyroidism but does not prevent aortic valve calcification in uremic rats.

Abu-Snieneh A, Gurt I, Abedat S, Lotan C, Glikson M, Shuvy M Front Nephrol. 2024; 4:1385705.

PMID: 39165274 PMC: 11333935. DOI: 10.3389/fneph.2024.1385705.


Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy.

Iop L Front Cardiovasc Med. 2021; 7:591583.

PMID: 33748193 PMC: 7969521. DOI: 10.3389/fcvm.2020.591583.


KPT-330 Prevents Aortic Valve Calcification via a Novel C/EBPβ Signaling Pathway.

Dutta P, Kodigepalli K, LaHaye S, Thompson J, Rains S, Nagel C Circ Res. 2021; 128(9):1300-1316.

PMID: 33601919 PMC: 8085092. DOI: 10.1161/CIRCRESAHA.120.318503.


Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment.

Kleinauskiene R, Jonkaitiene R Medicina (Kaunas). 2018; 54(2).

PMID: 30344255 PMC: 6037252. DOI: 10.3390/medicina54020024.


Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification.

Yu B, Hafiane A, Thanassoulis G, Ott L, Filwood N, Cerruti M JACC Basic Transl Sci. 2018; 2(4):358-371.

PMID: 30062157 PMC: 6034440. DOI: 10.1016/j.jacbts.2017.03.015.


References
1.
Mohler 3rd E, Adam L, McClelland P, Graham L, Hathaway D . Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol. 1997; 17(3):547-52. DOI: 10.1161/01.atv.17.3.547. View

2.
Weiss R, Ohashi M, Miller J, Young S, Heistad D . Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006; 114(19):2065-9. DOI: 10.1161/CIRCULATIONAHA.106.634139. View

3.
Jian B, Jones P, Li Q, Mohler 3rd E, Schoen F, Levy R . Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol. 2001; 159(1):321-7. PMC: 1850407. DOI: 10.1016/S0002-9440(10)61698-7. View

4.
Gu X, Masters K . Role of the MAPK/ERK pathway in valvular interstitial cell calcification. Am J Physiol Heart Circ Physiol. 2009; 296(6):H1748-57. PMC: 5243218. DOI: 10.1152/ajpheart.00099.2009. View

5.
Fujino T, Asaba H, Kang M, Ikeda Y, Sone H, Takada S . Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A. 2003; 100(1):229-34. PMC: 140935. DOI: 10.1073/pnas.0133792100. View